CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations
Author
Akimi Akashi
Atsushi Hirai
+53Â more
Barry
Bornhäuser
Chen
Cortes
Cortes
Daisuke Terada
DeZern
Fangli Chen
Fathi
Fiedler
Fischer
Fukushima
Fumihiko Hayakawa
Galanis
Griffith
Hayakawa
Hayato Ogura
Hitoshi Kiyoi
Kampa-Schittenhelm
Ken Uda
Kihara
Kiyoi
Kiyoi
Koichi Saito
Kottaridis
Levis
Levis
Ley
Masaru Takasaki
Meshinchi
Naoya Kurokawa
Norie Fujikawa
Roskoski
Shinji Hagiwara
Shiotsu
Smith
Smith
Smith
Smith
Stone
Stone
Takeshi Yamaura
Tomoki Naoe
Tomomi Date
Toshiyuki Nakatani
Wigyon Shin
Williams
Woyach
Yoshiya Adachi
Yuichi Ishikawa
Zarrinkar
Zimmerman
Zorn
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref
No full text
